SG11202005698XA - Cyclohexyl acid triazole azines as lpa antagonists - Google Patents
Cyclohexyl acid triazole azines as lpa antagonistsInfo
- Publication number
- SG11202005698XA SG11202005698XA SG11202005698XA SG11202005698XA SG11202005698XA SG 11202005698X A SG11202005698X A SG 11202005698XA SG 11202005698X A SG11202005698X A SG 11202005698XA SG 11202005698X A SG11202005698X A SG 11202005698XA SG 11202005698X A SG11202005698X A SG 11202005698XA
- Authority
- SG
- Singapore
- Prior art keywords
- azines
- cyclohexyl acid
- lpa antagonists
- acid triazole
- triazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762607383P | 2017-12-19 | 2017-12-19 | |
| US201862771214P | 2018-11-26 | 2018-11-26 | |
| PCT/US2018/066121 WO2019126093A1 (en) | 2017-12-19 | 2018-12-18 | Cyclohexyl acid triazole azines as lpa antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202005698XA true SG11202005698XA (en) | 2020-07-29 |
Family
ID=65003580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202005698XA SG11202005698XA (en) | 2017-12-19 | 2018-12-18 | Cyclohexyl acid triazole azines as lpa antagonists |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11267800B2 (en) |
| EP (1) | EP3728223B1 (en) |
| JP (1) | JP7208240B2 (en) |
| KR (1) | KR20200100719A (en) |
| CN (1) | CN112055711A (en) |
| AU (1) | AU2018392324A1 (en) |
| BR (1) | BR112020011965A2 (en) |
| CA (1) | CA3085561A1 (en) |
| ES (1) | ES2936517T3 (en) |
| IL (1) | IL275346A (en) |
| MX (1) | MX2020005323A (en) |
| SG (1) | SG11202005698XA (en) |
| TW (1) | TW202017918A (en) |
| WO (1) | WO2019126093A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR108838A1 (en) | 2016-06-21 | 2018-10-03 | Bristol Myers Squibb Co | CARBAMOYLOXIMETHYL ACID TRIAZOL CYCLOHEXILO AS LPA ANTAGONISTS |
| EP3728222B1 (en) * | 2017-12-19 | 2023-03-29 | Bristol-Myers Squibb Company | Cyclohexyl acid pyrazole azines as lpa antagonists |
| CN111434653A (en) * | 2019-01-15 | 2020-07-21 | 武汉朗来科技发展有限公司 | Triazole compound and preparation method and application thereof |
| MX2021012357A (en) * | 2019-04-16 | 2021-11-04 | Bristol Myers Squibb Co | Process for preparing carbamoyloxymethyl triazole cyclohexyl acid compounds. |
| EP4058144A1 (en) | 2019-11-15 | 2022-09-21 | Gilead Sciences, Inc. | Triazole carbamate pyridyl sulfonamides as lpa receptor antagonists and uses thereof |
| WO2021215484A1 (en) | 2020-04-21 | 2021-10-28 | 東レ株式会社 | Method for recovering rare metal salt |
| IL298082A (en) | 2020-06-03 | 2023-01-01 | Gilead Sciences Inc | Lpa receptor antagonists and uses thereof |
| US11702407B2 (en) | 2020-06-03 | 2023-07-18 | Gilead Sciences, Inc. | LPA receptor antagonists and uses thereof |
| CN112142716B (en) * | 2020-10-29 | 2021-08-31 | 山东新时代药业有限公司 | 5-membered heteroaryl substituted pyrazine derivative and application thereof |
| WO2022100623A1 (en) * | 2020-11-10 | 2022-05-19 | 武汉人福创新药物研发中心有限公司 | Nitrogen-substituted heterocyclic thiophene compounds and use thereof |
| CN114621135B (en) * | 2020-12-11 | 2024-01-30 | 上海拓界生物医药科技有限公司 | LPA1 small molecule antagonist |
| BR112023019388A2 (en) | 2021-03-23 | 2023-11-07 | Halia Therapeutics Inc | PYRIMIDINE DERIVATIVES USEFUL AS LRRK2 KINASE INHIBITORS |
| WO2022232459A1 (en) * | 2021-04-30 | 2022-11-03 | Viva Star Biosciences (Suzhou) Co., Ltd. | Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonists |
| KR20240005892A (en) | 2021-05-11 | 2024-01-12 | 길리애드 사이언시즈, 인코포레이티드 | LPA receptor antagonists and uses thereof |
| WO2023016521A1 (en) * | 2021-08-12 | 2023-02-16 | 上海赛默罗生物科技有限公司 | Substituted triazole derivative, preparation method therefor, pharmaceutical composition thereof, and use thereof |
| WO2023107938A1 (en) | 2021-12-08 | 2023-06-15 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
| TW202342017A (en) | 2022-02-25 | 2023-11-01 | 美商洛子峰生物有限公司 | Compounds and compositions for treating conditions associated with lpa receptor activity |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1364659B1 (en) | 2001-02-08 | 2009-11-11 | Ono Pharmaceutical Co., Ltd. | Remedies for urinary diseases comprising lpa receptor controlling agents |
| DE102004038403B4 (en) | 2004-08-07 | 2006-08-31 | Sanofi-Aventis Deutschland Gmbh | Process for preparing the enantiomeric forms of cis-configured 3-hydroxycyclohexanecarboxylic acid derivatives |
| US20080186971A1 (en) | 2007-02-02 | 2008-08-07 | Tarari, Inc. | Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic |
| EP2462128B1 (en) | 2009-08-04 | 2016-09-21 | Amira Pharmaceuticals, Inc. | Compounds as lysophosphatidic acid receptor antagonists |
| GB2474120B (en) | 2009-10-01 | 2011-12-21 | Amira Pharmaceuticals Inc | Compounds as Lysophosphatidic acid receptor antagonists |
| GB2474748B (en) | 2009-10-01 | 2011-10-12 | Amira Pharmaceuticals Inc | Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| BR112013014019A2 (en) | 2010-12-07 | 2016-09-13 | Amira Pharmaceuticals Inc | lysophosphatidic acid receptor antagonists and their uses |
| WO2012100436A1 (en) | 2011-01-30 | 2012-08-02 | Curegenix Inc. | Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof |
| EP2694472B1 (en) | 2011-04-05 | 2020-03-11 | Takeda Pharmaceutical Company Limited | Sulfonamide derivative and use thereof |
| WO2012138648A1 (en) * | 2011-04-06 | 2012-10-11 | Irm Llc | Compositions and methods for modulating lpa receptors |
| WO2013070879A1 (en) | 2011-11-10 | 2013-05-16 | Bristol-Myers Squibb Company | Methods for treating spinal cord injury with lpa receptor antagonists |
| WO2013085824A1 (en) | 2011-12-04 | 2013-06-13 | Angion Biomedica Corp. | Small molecule anti-fibrotic compounds and uses thereof |
| BR112014030685A2 (en) * | 2012-06-20 | 2017-06-27 | Hoffmann La Roche | n-alkyltriazole compounds as lpar antagonists |
| KR20150011389A (en) | 2012-06-20 | 2015-01-30 | 에프. 호프만-라 로슈 아게 | N-aryltriazole compounds as lpar antagonists |
| AR108838A1 (en) | 2016-06-21 | 2018-10-03 | Bristol Myers Squibb Co | CARBAMOYLOXIMETHYL ACID TRIAZOL CYCLOHEXILO AS LPA ANTAGONISTS |
| RS62710B1 (en) | 2017-12-19 | 2022-01-31 | Bristol Myers Squibb Co | Triazole n-linked carbamoyl cyclohexyl acids as lpa antagonists |
-
2018
- 2018-12-18 TW TW107145550A patent/TW202017918A/en unknown
- 2018-12-18 BR BR112020011965-2A patent/BR112020011965A2/en not_active Application Discontinuation
- 2018-12-18 US US16/772,825 patent/US11267800B2/en active Active
- 2018-12-18 CA CA3085561A patent/CA3085561A1/en not_active Abandoned
- 2018-12-18 KR KR1020207020548A patent/KR20200100719A/en not_active Application Discontinuation
- 2018-12-18 JP JP2020533680A patent/JP7208240B2/en active Active
- 2018-12-18 CN CN201880089627.5A patent/CN112055711A/en active Pending
- 2018-12-18 WO PCT/US2018/066121 patent/WO2019126093A1/en unknown
- 2018-12-18 ES ES18830681T patent/ES2936517T3/en active Active
- 2018-12-18 EP EP18830681.5A patent/EP3728223B1/en active Active
- 2018-12-18 MX MX2020005323A patent/MX2020005323A/en unknown
- 2018-12-18 AU AU2018392324A patent/AU2018392324A1/en not_active Abandoned
- 2018-12-18 SG SG11202005698XA patent/SG11202005698XA/en unknown
-
2020
- 2020-06-14 IL IL275346A patent/IL275346A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20210230143A1 (en) | 2021-07-29 |
| IL275346A (en) | 2020-07-30 |
| JP2021506860A (en) | 2021-02-22 |
| EP3728223B1 (en) | 2022-12-28 |
| KR20200100719A (en) | 2020-08-26 |
| JP7208240B2 (en) | 2023-01-18 |
| US11267800B2 (en) | 2022-03-08 |
| MX2020005323A (en) | 2020-08-13 |
| AU2018392324A1 (en) | 2020-08-06 |
| TW202017918A (en) | 2020-05-16 |
| CA3085561A1 (en) | 2019-06-27 |
| WO2019126093A1 (en) | 2019-06-27 |
| ES2936517T3 (en) | 2023-03-17 |
| CN112055711A (en) | 2020-12-08 |
| BR112020011965A2 (en) | 2020-11-17 |
| EP3728223A1 (en) | 2020-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275346A (en) | Cyclohexyl acid triazole azines as lpa antagonists | |
| IL275363A (en) | Cyclohexyl acid triazole azoles as lpa antagonists | |
| ZA201808580B (en) | Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonists | |
| IL275348A (en) | Triazole n-linked carbamoyl cyclohexyl acids as lpa antagonists | |
| IL269232B (en) | Fungicidal compositions | |
| PL3361870T3 (en) | Fungicidal compositions | |
| IL275361A (en) | Pyrazole n-linked carbamoyl cyclohexyl acids as lpa antagonists | |
| IL275534A (en) | Lysophosphatidylcholine compositions | |
| IL271604B (en) | Fungicidal compositions | |
| HUE058182T2 (en) | Griseofulvin compound | |
| PL3107392T3 (en) | Fungicidal compositions of pyrazolecarboxylic acid alkoxyamides | |
| PL3107391T3 (en) | Fungicidal compositions of pyrazolecarboxylic acid alkoxyamides | |
| GB2548744B (en) | Nail varnish composition | |
| PL3337322T3 (en) | Fungicidal compositions | |
| PL3426354T3 (en) | Compositions for nail varnish | |
| IL265634A (en) | Novel 5-substituted imidazolylmethyl derivatives | |
| PT3462873T (en) | Fungicidal compositions | |
| GB201617780D0 (en) | Sunless tanning compositions comprising caramel |